Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy

Myopic Traction Maculopathy Clinical Trial

Official title:

Efficacy of Surgical Treatment of Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02528045
• Other study ID #: Kyorineye017
• Status: Completed
• Phase: N/A
• First received: August 16, 2015
• Last updated: August 18, 2015
• Start date: June 2012
• Est. completion date: June 2015

Study information

• Verified date: August 2015
• Source: Kyorin University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Institutional review board: Japan
• Study type: Observational

Clinical Trial Summary

The medical records of 16 eyes of 16 patients with macular hole retinal detachment or myopic traction maculopathy who received viterctomy including internal limiting membrane peeling and scleral shorting surgery were reviewed. Best-corrected visual acuity, axial length, retinal reattachment and macular hole closure, the shape of staphyloma determined by optical coherence tomography and 3-dimensional magnetic resonance imaging were assessed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16
• Est. completion date: June 2015
• Est. primary completion date: July 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 90 Years

Eligibility

Inclusion Criteria:

• The inclusion criteria were patients who had highly myopic eyes with macular hole retinal detachment to myopic traction maculopathy

Exclusion Criteria:

• The patients with follow-up less than 6 months

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Macular Hole Retinal Detachment
• Myopia
• Myopic Traction Maculopathy
• Retinal Detachment
• Retinal Perforations

Intervention

Procedure:
• Vitrectomy with scleral shortening

Locations

Country	Name	City	State
Japan	Makoto Inoue	Mitaka	Tokyo

Sponsors (1)

Lead Sponsor	Collaborator
Kyorin University

Country where clinical trial is conducted

Japan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual acuity before and after surgery	Comparison with logarithm of Minimum Angle of Resolution (logMAR) vision	6 months	Yes
Secondary	Retinal reattachment	Retinal reattachment or resolution of myopic traction maculopathy	6 months	Yes